Clinical Research Services

The combination of the MHRA Accreditation and the expert knowledge of conducting 500 Early Phase Studies ensure Richmond Pharmacology can provide you with a service that meets your needs.

Adaptive Phase I Studies

Rapid approval, flexible conduct, government agency accredited facility, experienced

TQT Studies

Unique all under one roof setting, world-class specialist clinic and core laboratory



Bridiging Studies

Longstanding European specialist provider of Japanese and Japanese Bridging studies since 2002

Patient Recruitment

Innovative record breaking specialist early phase patient recruitment



Latest news

Dr Arezina article published in GMP review

16th Aug 2018

Richmond Pharmacology’s Research Director Dr Radivoj Arezina has written a piece for the July edition of GMP Review

Read more ›

Richmond Pharmacology Confirm event with the Department of International Trade

08th Aug 2018

Richmond Pharmacology is delighted to confirm an upcoming event alongside the Department of International Trade in

Read more ›

Officially an ILS Resuscitation Council Course Centre

07th Mar 2018

Richmond Pharmacology’s London Bridge Unit is now officially an ILS Resuscitation Council Course Centre. The

Read more ›

Bio Japan

10th Oct 2018

Bio Japan – 10–12 Oct, 2018 Pacifico Yokohama, Japan Richmond Pharmacology will be attending Asia’s

View event ›